OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
Luca Mastracci, Federica Grillo, Paola Parente, et al.
Pathologica (2022) Vol. 114, Iss. 5, pp. 352-364
Open Access | Times Cited: 24
Luca Mastracci, Federica Grillo, Paola Parente, et al.
Pathologica (2022) Vol. 114, Iss. 5, pp. 352-364
Open Access | Times Cited: 24
Showing 24 citing articles:
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Xu Yang, Baofeng Lian, Nan Zhang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Xu Yang, Baofeng Lian, Nan Zhang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 8
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 8
Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens
Federica Grillo, Michele Paudice, Alessandro Gambella, et al.
Histochemistry and Cell Biology (2023) Vol. 160, Iss. 2, pp. 113-125
Open Access | Times Cited: 10
Federica Grillo, Michele Paudice, Alessandro Gambella, et al.
Histochemistry and Cell Biology (2023) Vol. 160, Iss. 2, pp. 113-125
Open Access | Times Cited: 10
Organoid models: the future companions of personalized drug development
Francesco Piraino, Mariana Costa, Marine Meyer, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032009-032009
Open Access | Times Cited: 3
Francesco Piraino, Mariana Costa, Marine Meyer, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032009-032009
Open Access | Times Cited: 3
Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota
Pauline Raoul, Valeria De Gaetano, G Sciaraffia, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 357-357
Open Access | Times Cited: 3
Pauline Raoul, Valeria De Gaetano, G Sciaraffia, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 357-357
Open Access | Times Cited: 3
Predictive and prognostic biomarkers in gastrointestinal tract tumours
Klaudia Nowak, Runjan Chetty
Pathology (2024) Vol. 56, Iss. 2, pp. 205-213
Closed Access | Times Cited: 2
Klaudia Nowak, Runjan Chetty
Pathology (2024) Vol. 56, Iss. 2, pp. 205-213
Closed Access | Times Cited: 2
PD-L1 Expression in Colorectal Carcinoma Correlates with the Immune Microenvironment
Mohammed Shahin, Susama Patra, Suvendu Purkait, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 2, pp. 940-949
Closed Access | Times Cited: 2
Mohammed Shahin, Susama Patra, Suvendu Purkait, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 2, pp. 940-949
Closed Access | Times Cited: 2
A practical approach for PD-L1 evaluation in gastroesophageal cancer
Valentina Angerilli, Matteo Fassan, Paola Parente, et al.
Pathologica (2022) Vol. 115, Iss. 2, pp. 57-70
Open Access | Times Cited: 11
Valentina Angerilli, Matteo Fassan, Paola Parente, et al.
Pathologica (2022) Vol. 115, Iss. 2, pp. 57-70
Open Access | Times Cited: 11
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study
Alessandra Anna Prete, Paolo Manca, Marco Messina, et al.
European Journal of Cancer (2023) Vol. 182, pp. 87-97
Open Access | Times Cited: 6
Alessandra Anna Prete, Paolo Manca, Marco Messina, et al.
European Journal of Cancer (2023) Vol. 182, pp. 87-97
Open Access | Times Cited: 6
Plant‐derived Durvalumab variants show efficient PD‐1/PD‐L1 blockade and therapeutically favourable FcR binding
Shiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 5, pp. 1224-1237
Open Access | Times Cited: 6
Shiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 5, pp. 1224-1237
Open Access | Times Cited: 6
Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review
H. H. Wang, Ester Steffens, Gürsah Kats‐Ugurlu, et al.
Annals of Surgical Oncology (2023) Vol. 31, Iss. 1, pp. 433-451
Open Access | Times Cited: 5
H. H. Wang, Ester Steffens, Gürsah Kats‐Ugurlu, et al.
Annals of Surgical Oncology (2023) Vol. 31, Iss. 1, pp. 433-451
Open Access | Times Cited: 5
A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer
Magdalena Skórzewska, Katarzyna Gęca, Wojciech Polkowski
Cancers (2023) Vol. 15, Iss. 22, pp. 5490-5490
Open Access | Times Cited: 5
Magdalena Skórzewska, Katarzyna Gęca, Wojciech Polkowski
Cancers (2023) Vol. 15, Iss. 22, pp. 5490-5490
Open Access | Times Cited: 5
Claudin-18.2 immunohistochemical evaluation in gastric and gastroesophageal junction adenocarcinomas to direct targeted therapy: a practical approach
Matteo Fassan, Takeshi Kuwata, Kristina A. Matkowskyj, et al.
Modern Pathology (2024) Vol. 37, Iss. 11, pp. 100589-100589
Closed Access | Times Cited: 1
Matteo Fassan, Takeshi Kuwata, Kristina A. Matkowskyj, et al.
Modern Pathology (2024) Vol. 37, Iss. 11, pp. 100589-100589
Closed Access | Times Cited: 1
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials
Vincenzo Formica, Maria Cristina Morelli, Lorenzo Fornaro, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103967-103967
Open Access | Times Cited: 1
Vincenzo Formica, Maria Cristina Morelli, Lorenzo Fornaro, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103967-103967
Open Access | Times Cited: 1
Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
Victor Hugo Fonseca de Jesus, Rachel P. Riechelmann
Cancer Control (2023) Vol. 30
Open Access | Times Cited: 4
Victor Hugo Fonseca de Jesus, Rachel P. Riechelmann
Cancer Control (2023) Vol. 30
Open Access | Times Cited: 4
PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
Renato Lobrano, Panagiotis Paliogiannis, Angelo Zinellu, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 5135-5144
Open Access | Times Cited: 4
Renato Lobrano, Panagiotis Paliogiannis, Angelo Zinellu, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 5135-5144
Open Access | Times Cited: 4
Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine
Attila Molnár, Hunter L. Monroe, Hasan Basri Aydin, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 2388-2404
Open Access | Times Cited: 2
Attila Molnár, Hunter L. Monroe, Hasan Basri Aydin, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 2388-2404
Open Access | Times Cited: 2
Immunotherapy in gastrointestinal cancers: Spotlight on the pivotal role of currently available biomarkers
Valentina Angerilli, Juan José Andrade Rojas, Matteo Fassan
Elsevier eBooks (2024), pp. 83-102
Closed Access
Valentina Angerilli, Juan José Andrade Rojas, Matteo Fassan
Elsevier eBooks (2024), pp. 83-102
Closed Access
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)
Hirokazu Shoji, Chie Kudo‐Saito, Kengo Nagashima, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010174-e010174
Open Access
Hirokazu Shoji, Chie Kudo‐Saito, Kengo Nagashima, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010174-e010174
Open Access
Medullary carcinomas of the nonampullary small intestine: association with coeliac disease, mismatch repair deficiency, PD‐L1 expression, and favourable prognosis
Alessandro Vanoli, Federica Grillo, Giuseppe De Lisi, et al.
Histopathology (2024) Vol. 86, Iss. 2, pp. 236-246
Open Access
Alessandro Vanoli, Federica Grillo, Giuseppe De Lisi, et al.
Histopathology (2024) Vol. 86, Iss. 2, pp. 236-246
Open Access
Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice?
Victoria Kunene, Mingxing Ding, Mei Ling Yap, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 6, pp. 100091-100091
Open Access
Victoria Kunene, Mingxing Ding, Mei Ling Yap, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 6, pp. 100091-100091
Open Access
Programmed Death Ligand-1 Expression in Gastric Cancers Diagnosed at the University Teaching Hospitals in Lusaka, Zambia
Husna Munshi, Mupeta Songwe, Chibamba Mumba, et al.
Research Square (Research Square) (2024)
Open Access
Husna Munshi, Mupeta Songwe, Chibamba Mumba, et al.
Research Square (Research Square) (2024)
Open Access
PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
Yunjoo Cho, Soomin Ahn, Kyoung‐Mee Kim
Journal of the Korean Gastric Cancer Association (2024) Vol. 25, Iss. 1, pp. 177-177
Closed Access
Yunjoo Cho, Soomin Ahn, Kyoung‐Mee Kim
Journal of the Korean Gastric Cancer Association (2024) Vol. 25, Iss. 1, pp. 177-177
Closed Access
Evaluating Mismatch Repair Deficiency in Colorectal Cancer Biopsy Specimens
Federica Grillo, Michele Paudice, Alessandro Gambella, et al.
Research Square (Research Square) (2023)
Open Access
Federica Grillo, Michele Paudice, Alessandro Gambella, et al.
Research Square (Research Square) (2023)
Open Access
